8-K: Health Catalyst Reports Strong Q1 2025 Results, Exceeds Guidance

Health Catalyst announced first quarter 2025 financial results, exceeding guidance with $79.4 million in total revenue and $6.3 million in Adjusted EBITDA, and added 10 net new Platform Clients.

Summary

• Health Catalyst reported its financial results for the first quarter of 2025.
• Total revenue reached $79.4 million, a 6% increase year-over-year.
• Adjusted EBITDA was $6.3 million, representing an 86% increase year-over-year.
• The company added 10 net new Platform Clients during the quarter.
• Net loss for the quarter was $23.7 million.
• For the second quarter of 2025, Health Catalyst expects total revenue of approximately $80.5 million and Adjusted EBITDA of approximately $8 million.
• For the full year 2025, the company anticipates total revenue of approximately $335 million, technology revenue of approximately $220 million, and Adjusted EBITDA of approximately $41 million.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the company exceeding guidance and showing strong growth in Adjusted EBITDA. However, the net loss and some decreased margins temper the overall positive outlook.

Positives

• The company exceeded its Q1 2025 guidance for both total revenue and Adjusted EBITDA.
• There was a significant increase in Adjusted EBITDA compared to the same quarter last year.
• The addition of 10 net new Platform Clients in Q1 2025 is a positive indicator of growth.
• The company is confident in its ability to drive profitability and achieve its full-year 2025 targets.
• Health Catalyst expects meaningful improvement in stock-based compensation as a percentage of revenue, reducing to mid-to-high single digits by 2026.

Negatives

• The company reported a net loss of $23.7 million for the quarter.
• Gross profit decreased by 2% year-over-year.
• Gross margin decreased from 39% to 36% year-over-year.
• Net loss increased by 15% year-over-year.

Risks

• Changes in laws and regulations applicable to the business model could impact results.
• Changes in market or industry conditions and receptivity to technology and services pose a risk.
• The loss of one or more key clients or partners could adversely affect financial performance.
• Macroeconomic challenges, such as inflation, interest rates, and market volatility, could impact the business.
• The company faces risks related to recruiting and retaining qualified team members.

Future Outlook

Health Catalyst expects total revenue of approximately $80.5 million and Adjusted EBITDA of approximately $8 million for the second quarter of 2025. For the full year 2025, the company anticipates total revenue of approximately $335 million, technology revenue of approximately $220 million, and Adjusted EBITDA of approximately $41 million.

Management Comments

• Dan Burton, CEO of Health Catalyst, stated that he is pleased by the strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, which beat quarterly guidance on each metric.
• Dan Burton, CEO of Health Catalyst, stated that the addition of 10 net new Platform Clients in Q1 2025 is especially encouraging and gives the company increased confidence of hitting its target of 40 net new Platform Client additions in 2025.

Industry Context

Health Catalyst operates in the healthcare data and analytics technology and services market. The company's performance is influenced by factors such as healthcare organizations' operating margins, regulatory developments, and macroeconomic conditions. The company is actively tracking developments related to Medicaid, research funding and tariffs.

Comparison to Industry Standards

• It is difficult to provide a direct comparison to industry standards without specific competitor data.
• However, the company's focus on Adjusted EBITDA and platform client growth are common metrics used in the SaaS and healthcare technology industries.
• Companies like Cerner (now Oracle Health), Allscripts (now Veradigm), and athenahealth are comparible companies in the healthcare technology space.
• Comparing Health Catalyst's growth rate and profitability margins to these companies would provide a more detailed assessment of its performance relative to industry standards.

Stakeholder Impact

• Shareholders will likely react positively to the exceeded guidance and strong Adjusted EBITDA growth.
• Employees may be encouraged by the company's positive performance and outlook.
• Customers may benefit from the company's continued investment in its technology and services.
• Suppliers and creditors may view the company as a stable and reliable partner.

Next Steps

• The company will host a conference call on May 7, 2025, to review the results.
• The company expects to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025, on or about May 12, 2025.

Key Dates

Keywords

Health Catalyst, financial results, Adjusted EBITDA, revenue, platform clients, healthcare analytics, Q1 2025